UNSPSC 85323601: Diagnosis of polyclonal hypergammaglobulinaemia

This classification denotes the group of activities that yields a diagnosis of Polyclonal hypergammaglobulinaemia. Polyclonal hypergammaglobulinaemia is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code D89. 0

UNSPSC 85323601 Diagnosis of polyclonal hypergammaglobulinaemia (Commodity) shows a significant mismatch between its nominal scope—laboratory diagnostic testing for a specific immunological condition—and the work actually being solicited by state and local buyers under this code. Recent opportunities tagged to this code cover diagnostic imaging systems, ultrasound equipment procurement, and phlebotomy services, none of which align with serum protein electrophoresis or immunoglobulin-level testing. The issuing bodies are health care delivery systems and law enforcement agencies procuring capital equipment and clinical support services rather than laboratory diagnostics per se. San Mateo Medical Center (a county public hospital in California) is seeking an enterprise-grade Picture Archiving and Communication System for radiology, cardiology, and dental imaging with EPIC integration; Collier County, Florida, is single-sourcing ultrasound equipment from EchoNous; and the Albuquerque Police Department is establishing an on-call phlebotomy service contract. The code shows minimal relevant recent activity aligned with its stated diagnostic scope.

Geographic activity centers on California (San Mateo County) and Florida (Collier County), with one opportunity in New Mexico. The San Mateo Medical Center RFP (Solicitation 660002526251, due August 7, 2026) is the most substantial recent posting and represents typical state and local health care procurement under this misclassified code—a systems integration and data migration project rather than diagnostic testing. Collier County's single-source notice for ultrasound equipment (Solicitation PUR16842, posted April 1, 2026) and APD's phlebotomy services RFB (RFB-2025-748-POL-DZ, due February 25, 2026) suggest that this code may be applied inconsistently across health care and law enforcement procurement without clear alignment to the polyclonal hypergammaglobulinaemia diagnosis taxonomy it nominally describes. Firms pursuing this code should expect to encounter imaging-system implementations, point-of-care equipment, and ancillary clinical-service contracts rather than laboratory diagnostics.